Mutational activation of Ras promotes oncogenesis by controlling cell cycle regulation and cell survival. Rasmediated activation of both, the PI3K/AKT pathway and the MEK/ERK pathway, can trigger downregulation of the function of tuberin to block the activities of mTOR and p70S6K. Here we demonstrate that Ras-induced cell survival is accompanied by upregulation of p70S6K activity. Ras harbors the potential to negatively affect tuberin-induced apoptosis and p70S6K inactivation. These effects of Ras were found to depend on its potential to regulate the MEK/ERK pathway. Experiments using tuberin-negative fibroblasts revealed that the potential of Ras to counteract apoptosis depends on functional tuberin. Taken together, we provide evidence that the function of Ras to trigger inactivation of tuberin plays a major role in the regulation of cell survival upon mutational activation of the oncogene Ras. This is the first description of a functional interaction between the tumor suppressor tuberin and the oncogene Ras in regulating apoptosis.
Introduction
Ras proteins are GTP-regulated molecular switches for signaling pathways involved in a wide variety of different cellular processes. In many very different types of tumors mutational oncogenic activation causes Ras to become insensitive to negative regulation by GTPaseactivating proteins and to remain constitutively active. The potential of so activated Ras to induce cell proliferation is involved in the process of Ras-mediated transformation (Shaw and Cantley, 2006) . In addition, the development and maintenance of these tumors also depend on the potential of mutationally activated Ras to mediate cell survival. As a result the tumor cells are relatively resistant to apoptosis (Cox and Der, 2003; Downward, 2004) . Two major downstream targets of Ras have been shown to be able to mediate its antiapoptotic effects. First, Ras binds to and activates the p110 catalytic subunit of the phosphatidylinositide-3 0 -OH kinase (PI3K). Phosphorylation of the membrane lipid phosphatidylinositol 4,5-biphosphate by PI3K produces the second messenger phosphatidylinositol 3,4,5-triphosphate, which then activates AKT. Second, the serine/threonine kinase Raf-1 links Ras to the extracellular signal-regulated kinase (ERK) mitogenactivated protein kinase (MAPK) pathway. The Raf/ MEK/ERK cascade leads to ERK phosphorylation and activation of p90S6K (RSK; Shaw and Cantley, 2006) . Both, the PI3K/AKT cascade and the MEK/ERK pathway, are known to regulate cell survival. However, whether mutational activation of Ras induces cell survival and which of these two pathways is induced depends greatly on the cell type (Cox and Der, 2003; Franke et al., 2003; Downward, 2004) .
Tuberin is regulated by both, the PI3K/AKT and the MEK/ERK pathway. Tuberin, encoded by TSC2, forms a heterodimer with the TSC1 gene product hamartin. Mutations in one of these two tumor suppressor genes are responsible for the autosomal dominant tumor syndrome tuberous sclerosis (TSC). TSC is characterized by the development of tumors, named hamartomas, in the kidneys, heart, skin and brain (Kwiatkowski, 2003; Astrinidis and Henske, 2005) . Tuberin is phosphorylated by AKT on Ser939 and Thr1462, and through an unknown mechanism, this phosphorylation inhibits the ability of tuberin to act as a GTPaseactivating protein against Rheb, which in turn regulates mTOR. Accordingly, AKT is assumed to stimulate mTOR signaling by inhibiting the function of tuberin (Dan et al., 2002; Inoki et al., 2002; Manning et al., 2002; Potter et al., 2002) . mTOR phosphorylates p70S6K on Thr389, which correlates with activation of p70S6K (Dufner and Thomas, 1999; Li et al., 2003; Pan et al., 2004) . In agreement with the postulated cascade described above, it was found that overexpression of tuberin suppresses phosphorylation of p70S6K on residue Thr389 (representing S6K activity) (Dan et al., 2002; Goncharova et al., 2002; Inoki et al., 2002; Manning et al., 2002; Potter et al., 2002; Tee et al., 2002) . In addition, ERK-mediated phosphorylation of tuberin on Ser664 negatively regulates tuberin's function by blocking its interaction with hamartin. RSK-dependent phosphorylation of tuberin on Ser1798 inhibits its potential to turn off Rheb (Roux et al., 2004; Ballif et al., 2005; Ma et al., 2005) . The role of phosphorylation by AKT, ERK or RSK for tuberin's other known functions has not been investigated in detail, so far. Tuberin has been implicated in the regulation of endocytosis (Xiao et al., 1997) , transcription (Henry et al., 1998) or neuronal differentiation (Soucek et al., 1998a) . Tuberin also regulates cell cycle progression. Tuberin binds to the cyclin-dependent kinase inhibitor p27 and, thereby, prevents p27 degradation via its SCFtype E3 ubiquitin ligase complex (Soucek et al., 1997 (Soucek et al., , 1998b Miloloza et al., 2000; Rosner and Hengstschla¨-ger, 2004) .
Recently, tuberin has also been implicated in the regulation of apoptosis. Under energy starvation conditions, the AMP-activated protein kinase (AMPK) phosphorylates tuberin on residues Thr1227 and Ser1345. This phosphorylation by AMPK activates tuberin, is required for the regulation of cell size control, and protects cells from energy deprivation-induced apoptosis . In addition, it was reported that the Rheb/mTOR/p70S6K cassette imposes a negative feedback program to attenuate IRS-dependent processes such as cell survival (Shah et al., 2004) . Ectopic TSC2 expression increases the susceptibility of the TSC2-null renal tumor cell line ERC-18 to apoptosis induced by okadaic acid and the PI3K inhibitor, LY294002 (Kolb et al., 2005) . Furthermore, tuberin's negative effects on p70S6K activity trigger downregulation of the phosphorylation of the proapoptotic molecule BAD on Ser136. These effects on BAD phosphorylation cause an upregulation of the interaction of BAD/BCL-2 and BAD/BCL-X L leading to induction of apoptosis. These findings demonstrated that depending on the exogenous triggers and on the cellular background tuberin is a positive regulator of apoptosis (Freilinger et al., 2006) .
Here, we describe that Ras blocks tuberin-mediated apoptosis. We found these effects to depend on the potential of Ras to regulate the MEK/ERK pathway. In this study the tumor suppressor protein tuberin is identified as a major regulator of cell survival mediated by mutationally activated oncogenic Ras.
Results
Ras-mediated cell survival is accompanied by upregulation of p70S6K activity Mutationally activated Ras is known to mediate cell survival in transformed cells (Cox and Der, 2003; Downward, 2004) . In the recent past we have used the tumor-derived HeLa cell line to demonstrate tuberin's proapoptotic function via regulating p70S6K (Freilinger et al., 2006) . Ectopic expression of mutationally activated Ras is a well-established and widely used experimental approach to mimic the situation of tumor cells harboring constitutively active Ras, which is insensitive to negative regulation by GTPase-activating proteins.
HeLa cell pools were selected for ectopic expression of activated mutant RasG12V (RasV12) (Figure 1a ). Wellknown features of cells undergoing apoptosis are DNA fragmentation, nuclear chromatin condensation, cleavage of poly(ADP-ribose)polymerase (PARP), or cleavage of caspase 3 (Danial and Korsmeyer, 2004) . After transferring these cells into 0.1% fetal calf serum (FCS) for 48 h, DNA fragmentation was investigated by the detection of cells with subG1 DNA content. A significant decrease of subG1 cells was detected upon RasV12 expression (Figure 1b) . Furthermore, so treated cells were stained with Hoechst 33258/propidium-iodide (HOPI) to monitor nuclear chromatin condensation and apoptosis. Viable and apoptotic cells were discerned and counted under the microscope. Quantitative analyses of the percentage of dead cells revealed that RasV12 significantly reduced apoptosis in 0.1% FCS (Figure 1c ). Western blot analyses revealed that cleavage of both, PARP and caspase 3, is downregulated by RasV12 under these experimental conditions (Figure 1d ).
Collectively, these data demonstrate that activated Ras mediates cells survival in HeLa cells.
Since activated Ras is known to harbor the potential to upregulate p70S6K (see Introduction), it was of interest to investigate whether Ras-mediated cell survival is accompanied by upregulation of p70S6K activity under the here chosen experimental conditions. Western blot analysis demonstrated that RasV12 increased the phosphorylation status of the major p70S6K target S6 (Figure 1d ). Here, it is important to note that throughout the entire study exclusively antibodies were used, which have been demonstrated to specifically and correctly detect the phosphorylated proteins in all the publications cited in the introduction.
To investigate whether transiently expressed RasV12 also reduces cell death of HeLa cells in 0.1% FCS we performed luciferase assays. Luciferase activities are indirect indicators for apoptosis. In cell populations with more luciferase activity in the lysates, more cells are viable and less apoptosis is present (see for example, Harada et al., 2001; Wohlfart et al., 2004; Freilinger et al., 2006) . Ras-mediated cell survival was also detectable performing luciferase assays (Figure 1e) . Furthermore, the potential of Ras to activate p70S6K activity was confirmed in transient expression experiments. Again, we found Ras to induce phosphorylation of the p70S6K target S6. Ras is even able to activate high levels of ectopic p70S6K protein (Figure 1f ). The induction of S6 phosphorylation could also be detected in cells expressing low amounts of ectopic RasV12, what provides additional support for the biological relevance of this finding (Figure 1g ). Taken together, these data demonstrate that activated Ras mediates cell survival accompanied by upregulation of p70S6K activity.
Ras negatively affects tuberin-induced apoptosis
Recently, we reported that in selection experiments as well as in transient approaches ectopic expression of wild-type TSC2 induces apoptosis (Freilinger et al., 2006) . Here, flowcytometric analyses of the amount of subG1 cells, detection of caspase 3 cleavage and PARP cleavage by western blotting confirmed this potential of tuberin (Figures 2a-d) . Coexpression of high as well as of low levels of ectopic RasV12 negatively regulated tuberin's proapoptotic potential, studied on the effects of tuberin on the amount of subG1 cells. The observation that Ras alone and Ras þ TSC2 trigger similar effects suggests that Ras is indeed very efficient in inactivating even ectopic tuberin (Figure 2a ). To confirm this finding using an additional approach, we induced the MAPK pathway by phorbol-12-myristate-13-acetate The mean of the cells kept in 10% serum was set as 100%. (f) HeLa cells were transiently transfected with the empty vector control, p70S6K, or p70S6K þ RasV12. Cotransfection with p70S6K was performed to allow a better visualization of the effects of Ras on this kinase. Twenty-four hour after transfection, cells were kept in 0.1% serum for additional 24 h before protein extraction. Immunoblot analyses of Ras, phosphorylated p70S6K (Thr389), total p70S6K, phosphorylated S6 (Ser235/236), total S6 and a-tubulin were performed. Endogenous Ras and p70S6K proteins are not detectable on the chosen exposures. (g) HeLa cells were transfected with RasV12 as described above and with decreasing amounts (0.5 Â and 0.25 Â ) of RasV12 expression vector. RasV12, phosphorylated S6, total S6 and a-tubulin protein levels were analysed 48 h after transfection (24 h in 0.1% FCS).
Ras mediates cell survival by regulating tuberin
A Freilinger et al (PMA) treatment (compare induction of RSK1 phosphorylation by PMA, Figure 2b ) and blocked endogenous Ras activity by expressing the dominant negative mutant RasN17. These experiments revealed that PMAmediated cell survival over tuberin-induced apoptosis could be blocked by the dominant negative Ras mutant (Figures 2a and b ). These findings prove that PMA negatively affects tuberin's apoptotic potential via activating Ras.
In selection experiments RasV12 also negatively affected tuberin's potential to induce DNA fragmentation ( Figure 2c ) and PARP cleavage (Figure 2d ). Taken Figure 2 Ras negatively affects tuberin-induced apoptosis. (a) HeLa cells were transfected with empty vector control, TSC2, TSC2 þ RasV12, RasV12 alone, TSC2 þ decreased amounts of RasV12 (low) or decreased amounts of RasV12 (low) alone. In addition, HeLa cells were transfected with empty vector control, TSC2 or TSC2 þ the dominant negative Ras mutant RasN17 and were treated with the MAPK pathway inducer phorbol-12-myristate-13-acetate (PMA) for 24 h. All transfectants were cotransfected with a GFP expression plasmid. Apoptosis induced by treatment with 0.1% FCS for 24 h was cytofluorometrically analysed via determination of subG1 cells (DNA degradation) within the GFP-positive cell pools. All results represent means ± s.d. TSC2-induced apoptosis was significantly diminished by RasV12, independently of the high and lower expression level. In addition, the PMA-induced downregulation of TSC2-mediated apoptosis could be blocked by coexpression of the dominant negative Ras mutant (Po0.05; Student's t-test). (b) HeLa cells transfected with empty vector control, TSC2, or TSC2 þ RasN17 with and without phorbol-12-myristate-13-acetate (PMA) treatment were studied for caspase 3 cleavage and RSK1 phosphorylation status by western blot analysis. Signals for cleaved caspase 3 were densitometrically normalized to a-tubulin. (c) HeLa cells were transfected with mammalian expression vectors, either empty as a control, or harboring full-length wild-type TSC2 cDNA or RasV12 cDNA. G418 selection for transfected cells was started 24 h after transfection. Selected cell pools were grown in 0.1% FCS for 48 h plus and minus the MEK inhibitor U0126. DNA content (amount of subG1-cells) was determined on the flow cytometer after propidium iodide staining. All results represent means ± s.d. The percentage of cells with subG1 DNA content induced by TSC2 expression significantly decreased upon coexpression of RasV12 and the negative effects of U0126 on Ras-mediated cell survival were also proven to be statistically significant (Po0.05; Student's t-test). (d) Protein extracts from cell pools transfected and treated as described in (c) were analysed for poly(ADP-ribose)polymerase (PARP) cleavage by western blotting.
Ras mediates cell survival by regulating tuberin A Freilinger et al together, these data provide evidence that activation of Ras, either by mutational activation (ectopic RasV12 expression) or by PMA activation of endogenous Ras, mediates cell survival over tuberin-induced apoptosis.
Ras triggers cell survival accompanied by upregulation of ERK activity From the data obtained so far it was tempting to speculate that activated Ras could mediate its antiapoptotic effects via negatively regulating tuberin. As described in the introduction, mutationally activated Ras can trigger its cell survival effects via activating the PI3K/AKT pathway or via the MEK/ERK pathway. The effects of Ras on cell survival and the pathway used to mediate these effects depend on the cellular background and on the context. Besides regulating a wide variety of other targets, these two pathways trigger phosphorylation and inactivation of tuberin (see Introduction and Figure 3a) . Next, we wanted to investigate whether the activities of AKT, ERK or both are induced by RasV12 under the experimental conditions for the detection of Ras-mediated cell survival over TSC2-induced apoptosis.
We found Ras-mediated cell survival effects over TSC2-induced apoptosis (Figure 2 ) not to be accompanied by an induction of AKT activity (represented by phosphorylated AKT Ser473) or AKT-mediated tuberin phosphorylation (represented by phosphorylated tuberin Ser939 or Thr1462). On the other hand the cell survival effects of Ras were accompanied by a strong upregulation of ERK activity (represented by phosphorylated ERK1/2 Thr202/Tyr204) and by upregulation of the activity of p70S6K (represented by the phosphorylation status of the major p70S6K target S6) (Figures 3b and c) . These findings show that under the here chosen experimental conditions activated Ras mediates cell survival accompanied by upregulation of ERK activity and p70S6K activity, but has no effects on AKT activity.
Ras-induced cell survival depends on its potential to regulate the MEK/ERK/RSK pathway Accordingly, blocking the MEK/ERK/RSK pathway should negatively affect the cell survival potential of Ras over tuberin-induced apoptosis. To test this assumption, we made use of the well-known MEK inhibitor U0126. Ras-mediated activation of ERK activity (represented by the phosphorylation status of ERK1/2 Thr202/ Tyr204) and of RSK activity (represented by the phosphorylation status of RSK1 Ser380) could efficiently be blocked by U0126 treatment (Figure 4a ). Detection of PARP cleavage (Figure 4a ) and analysing the amount of subG1 cells (Figure 2c ) demonstrated that this U0126-mediated block of the MEK/ERK/RSK cascade triggered a significant loss of the potential of Ras to mediate cell survival over tuberin-induced apoptosis.
The findings described so far strongly suggest that Ras mediates cell survival by inducing mTOR activity via blocking tuberin to downregulate mTOR (Figure 3a) . In perfect agreement with this model, we found that Ras cannot mediate cell survival with the same efficiency in cells treated with the widely used mTOR inhibitor rapamycin (Figure 4b) .
Further support for the model that activated Ras mediates cell survival by negatively regulating tuberin via the MEK/ERK/RSK cascade came from experiments using the TSC2 S1798A mutant. This mutant was used to prove that RSK-dependent phosphorylation of tuberin on Ser1798 inhibits its potential to turn off Rheb and to downregulate the activities of mTOR and p70S6K. Mutation of Ser1798 inhibited most of tuberin phosphorylation and inactivation by RSK (Roux et al., 2004) . Investigating PARP cleavage, caspase 3 cleavage, Figure 4 Ras-mediated cell survival depends on its potential to regulate the MEK/ERK/RSK pathway and mTOR. (a) HeLa cells were transfected with empty control vector, RasV12, or with TSC2 þ RasV12. After 24 h in 0.1% serum, cells were kept in 0.1% serum for additional 24 h plus and minus treatment with the MEK inhibitor U0126 before protein extraction. Immunoblot analyses of tuberin, Ras, phosphorylated ERK1/2 (Thr202/Tyr204), total ERK1/2, phosphorylated RSK1 (Ser380), total RSK1/2/3, cleaved PARP and a-tubulin were performed. Signals for cleaved PARP were normalized to a-tubulin. (b) HeLa cells were transfected with empty control vector, RasV12, or with TSC2 þ RasV12. After 24 h in 0.1% serum, cells were kept in 0.1% serum for additional 10 h plus and minus treatment with the mTOR inhibitor rapamycin before protein extraction. Immunoblot analyses of tuberin, Ras, cleaved PARP, phosphorylated S6, total S6 and a-tubulin were performed. Signals for cleaved PARP were normalized to a-tubulin. (Figures 5a-c) . In other words, apoptosis induced by a TSC2 mutant, which cannot efficiently be phosphorylated and inactivated by RSK, is more resistant to RasV12-mediated cell survival.
To test again whether phosphorylation of tuberin by AKT plays a role in Ras-mediated cell survival we next made use of the TSC2 SATA mutant, harboring mutations of the major AKT phosphorylation sites Ser939 and Thr1462. We found these mutations to not affect the cell survival effects of Ras over tuberininduced apoptosis (Figures 5d and e) .
In summary, these data provide evidence that Ras triggers its cell survival effects by activating the MEK/ ERK/RSK pathway leading to phosphorylation and inhibition of the proapoptotic molecule tuberin.
Tuberin plays a major role for Ras-mediated cell survival To confirm that tuberin plays a major role for Rasmediated cell survival we made use of TSC2 þ / þ and TSC2À/À fibroblasts (Figure 6a ). Analysing the amount of subG1 cells and studying PARP cleavage demonstrated that activated Ras mediates cell survival over low serum-induced apoptosis also in TSC2 þ / þ fibroblasts. These Ras-mediated antiapoptotic effects were significantly diminished in the tuberin-negative counterparts. This is even more remarkable given that the expression level of ectopic RasV12 was slightly higher in TSC2À/À cells compared to TSC2 þ / þ cells Figure 5 Ras-mediated cell survival is affected by mutation of the RSK phosphorylation site, but not by mutations of the AKT phosphorylation sites of tuberin. (a) HeLa cells were transfected with mammalian expression vectors harboring RasV12, full-length wild-type TSC2 cDNA or the TSC2 S1798A mutant, plus and minus cotransfection of RasV12. Protein levels of tuberin, Ras, phosphorylated S6, total S6, cleaved PARP, cleaved caspase 3 and a-tubulin were studied by western blot analysis after 24 h induction of apoptosis in 0.1% FCS. (b) G418 selection for cells transfected as described above was started 24 h after transfection. Selected cell pools were transferred into 0.1% FCS for 48 h and were stained with Hoechst 33258/propidium-iodide (HOPI) to monitor nuclear chromatin condensation and cell death. All results represent means ± s.d. The antiapoptotic effect of Ras was significantly lower in cells transfected with the TSC2 S1798A mutant compared to cells transfected with wild-type TSC2 (Po0.05; Student's t-test). (c) DNA content of cells described in (b) was determined on the flow cytometer after propidium iodide staining. All results represent means±s.d. The antiapoptotic effect of Ras was significantly lower in cells transfected with the TSC2 S1798A mutant compared to cells transfected with wild-type TSC2 (Po0.05; Student's t-test). (d) HeLa cells were transfected with mammalian expression vectors harboring RasV12, full-length wild-type TSC2 cDNA or the TSC2 SATA mutant (Ser9393A, Thr1462A), plus and minus cotransfection of RasV12. Protein levels of tuberin, Ras and a-tubulin were studied by western blot analysis. (e) G418 selection for cells transfected as described in (d) was started 24 h after transfection. Selected cell pools were transferred into 0.1% FCS for 48 h and DNA content was determined on the flow cytometer after propidium iodide staining. All results represent means±s.d. The TSC2 SATA mutation did not affect the antiapoptotic effects of Ras over TSC2.
A Freilinger et al (Figures 6b and c) . Here it is important to note that (although clearly diminished) Ras still mediated antiapoptotic effects also in TSC2À/À cells suggesting that besides regulating tuberin, Ras can also use tuberinindependent mechanisms to regulate cell survival. Still, even the effects of low RasV12 expression levels were dependent on endogenous tuberin, as proven by analyses of PARP cleavage and caspase 3 cleavage upon ectopic RasV12 expression in TSC2 þ / þ and TSC2À/À cells (Figure 6d) . Furthermore, analysing caspase 3 cleavage and the percentage of subG1 cells revealed that upon reintroduction of TSC2 into TSC2À/À cells Ras more efficiently mediates cell survival over low serum-induced apoptosis (Figures 7a and b ; P>0.05; Student's t-test).
Here it is important to note that the absolute percentages of subG1 cells reflecting apoptosis induced via low serum in TSC2À/À cells found in Figure 6b (transfections with pCMV expression vectors) and in Figure 7b (cotransfections with pRK7 expression vectors) are not comparable due to different expression vectors.
To analyse the functional interaction of tuberin and Ras in regulating apoptosis induced by another stimulus, we made use of staurosporine, another well-known inducer of apoptosis (see for example, Arrebola et al., 2005; Freilinger et al., 2006) . We found that upon reintroduction of TSC2 into TSC2À/À cells Ras more efficiently mediates cell survival also over staurosporineinduced apoptosis (Figure 7c ; P>0.05; Student's t-test).
Taken together, these findings allow the conclusion that tuberin is a major mediator of Ras-induced cell survival.
Discussion
Uncontrolled cell cycle progression is a key property of tumor cells and survival and further progression of only rare neoplastic cells is allowed by defects in the regulation of apoptosis. Mutationally activated Ras has been demonstrated to be involved in the regulation of both, cell cycle control and cell survival. Performing analyses of the amount of subG1 cells (apoptosis-specific DNA degradation) or of HOPI-positive cells (apoptosis-specific nuclear chromatin condensation), studying apoptosisspecific cleavage of PARP and caspase 3, and analysing cell viability in luciferase assays revealed that short-term (transient transfection with RasV12) and long-term (selection for RasV12-transfected cells) activation of Ras triggers cell survival over low serum-induced apoptosis in HeLa cells. We used the HeLa cell line for this study, because it is a tumor-derived line and mutationally activated Ras is known to mediate cell survival especially in transformed cells (Cox and Der, 2003) . Furthermore, Figure 6 Ras-mediated cell survival depends on endogenous tuberin. (a) TSC2 þ / þ and TSC2À/À cells were analysed for tuberin expression by western blotting. The asterisk indicates an unspecific band. (b) TSC2 þ / þ and TSC2À/À cells were transiently transfected with the empty control vector or with RasV12. Cells were cotransfected with a GFP expression plasmid. Apoptosis induced by treatment with 0.1% FCS for 24 h was cytofluorometrically analysed via determination of subG1 cells (DNA degradation) within the GFP-positive cell pools. All results represent means ± s.d. Ras-mediated cell survival over low seruminduced apoptosis was significantly diminished in TSC2À/À cells compared to TSC2 þ / þ cells (Po0.05; Student's t-test). (c) In addition, in the experiments described in (b), the effects of RasV12 on PARP cleavage in TSC2À/À cells were compared to the effects in TSC2 þ / þ cells by western blotting. Signals for cleaved PARP were normalized to a-tubulin. (d) TSC2 þ / þ and TSC2À/À cells were transfected with RasV12 and with decreased amounts of RasV12 (low). Twenty-four hours after transfection apoptosis was induced with 0.1% FCS for 24 h and protein levels of Ras, cleaved PARP, cleaved caspase 3, phosphorylated S6, total S6 and atubulin were studied by western blot analysis.
in the recent past we have also used HeLa cells to demonstrate tuberin's proapoptotic function via regulating p70S6K (Freilinger et al., 2006) . However, in the here presented report we also found activated Ras to mediate cell survival effects in non-transformed TSC2 þ / þ fibroblasts. Figure 7 Tuberin's role in Ras-mediated cell survival. (a) TSC2À/À cells were transfected with RasV12, TSC2 or both. Twenty-four hours after transfection apoptosis was induced with 0.1% FCS for 24 h and protein levels of tuberin, Ras, cleaved caspase 3 and a-tubulin were studied by western blot analysis. Signals for cleaved caspase 3 were densitometrically normalized to a-tubulin. (b) TSC2À/À cells were transiently transfected with the empty control vector, with RasV12, TSC2, or both. Cells were cotransfected with a GFP expression plasmid. Apoptosis induced by treatment with 0.1% FCS for 24 h was cytofluorometrically analysed via determination of subG1 cells (DNA degradation) within the GFP-positive cell pools. All results represent means±s.d. Upon reintroduction of TSC2 into TSC2À/À cells Ras mediates cell survival over low serum-induced apoptosis more efficiently (Po0.05; Student's t-test). (c) TSC2À/À cells were transiently transfected with the empty control vector, with RasV12, TSC2 or both. Cells were cotransfected with a GFP expression plasmid. Apoptosis induced by treatment with 25 nM staurosporine for 120 min was cytofluorometrically analysed via determination of subG1 cells (DNA degradation) within the GFP-positive cell pools. All results represent means±s.d. Upon reintroduction of TSC2 into TSC2À/À cells Ras mediates cell survival over staurosporine-induced apoptosis more efficiently (Po0.05; Student's t-test).
The tumor suppressor tuberin is well known to be a potent negative regulator of cell cycle and cell size control (see Introduction). Recently, we demonstrated that high levels of tuberin trigger apoptosis by downregulating p70S6K activity. These effects lead to downregulation of BAD phosphorylation on residue Ser136, and to upregulation of the interaction between BAD and BCL-2 or BCL-X L (Freilinger et al., 2006) . In this report we describe that (1) Ras negatively regulates tuberin-induced apoptosis. (2) In the same cells activated Ras also downregulates tuberin's potential to block p70S6K activity. (3) The Ras-mediated antiapoptotic effects are stronger in cells expressing ectopic TSC2 wt, than in cells expressing a TSC2 S1798A mutant that cannot be phosphorylated and inhibited by RSK anymore. (4) The potential of Ras to induce cell survival is diminished in TSC2À/À cells compared to TSC2 þ / þ cells. (5) Ras more efficiently mediates antiapoptotic effects in TSC2À/À cells upon reintroduction of TSC2. Taken together, these findings demonstrate tuberin to be a major mediator of Ras-induced cell survival. On the other hand, our finding that the antiapoptotic potential of Ras over low serum-induced apoptosis is diminished but not completely lost in TSC2À/À cells suggests that Ras can also trigger cell survival in a tuberin-independent manner.
Two cascades are known to be regulated by Ras and to harbor the potential to negatively affect tuberin's function. The PI3K/AKT pathway controls phosphorylation of tuberin by AKT, and this phosphorylation inhibits the ability of tuberin to act as a negative regulator of mTOR/p70S6K. Ras regulates Raf upstream of MEK/ERK/RSK. Both, ERK-mediated phosphorylation of tuberin and RSK-dependent phosphorylation of tuberin, inhibit its potential to block mTOR/p70S6K (Dan et al., 2002; Inoki et al., 2002; Manning et al., 2002; Potter et al., 2002; Roux et al., 2004; Ballif et al., 2005; Ma et al., 2005) . Since Ras regulates different pathways, it is likely that the selection of distinct effectors can lead to different outcomes. This selection depends on the cellular background and on the context (Cox and Der, 2003; Franke et al., 2003; Downward, 2004) . In HeLa cells we found Rasmediated cell survival to be accompanied by upregulation of the endogenous MEK/ERK/RSK pathway. Under the here chosen experimental conditions we found Ras to trigger its antiapoptotic effects without affecting endogenous AKT activity or AKT-dependent phosphorylation of tuberin Ser939 or Thr1462. On the other hand, activated Ras is well known to trigger cell survival by regulating the PI3K/AKT pathway in other cells and/or under other experimental conditions (Downward, 2004; Shaw and Cantley, 2006) . It is important to note that our here presented data do not exclude the possibility that Ras triggers cell survival by inducing AKT to phosphorylate and inhibit the proapoptotic molecule tuberin in other cells. This is even more important to consider, since we earlier found that high ectopic levels of AKT activity can negatively regulate tuberin-mediated apoptosis (Freilinger et al., 2006) . In the past, different studies have shown that the Raf/ MEK/ERK/RSK pathway can mediated both anti-and proapoptotic effects, depending on the different regulated targets in different cells and in different biological environments (Cox and Der, 2003) . For the first time, in this study we provide evidence that Ras can use this pathway to mediate cell survival via inhibition of the proapoptotic effects of tuberin (Figure 3) .
A wide variety of different types of tumors harbor mutationally activated oncogenic Ras (Shaw and Cantley, 2006) . The development of these tumors as well as its maintenance depends on activated Ras to avoid apoptosis (Cox and Der, 2003) . Here we provide the first functional connection between the oncogene Ras and the tumor suppressor protein tuberin. Further molecular understanding of Ras-mediated effects are of relevance for all types of tumors harboring mutationally activated Ras. Furthermore, understanding of the role of the TSC genes has not only implications for TSC patients but also for sufferers from other cancers that may involve the TSC proteins. So far, TSC gene mutations have also been shown in sporadic bladder cancer (Hornigold et al., 1999; Adachi et al., 2003; Knowles et al., 2003a) and in breast cancer (Jiang et al., 2005) . Deletions in the TSC gene regions are also found at significant frequency in ovarian and gall bladder carcinoma and non-small cell carcinoma of the lung (Knowles et al., 2003b) . A loss of the proapoptotic function of tuberin might be involved in the development and survival of these tumors. It could be speculated that activation of tuberin might be a useful therapeutic intervention concept in these cases.
Materials and methods
Cells, tissue culture, flow cytometry, apoptosis detection HeLa (human cervical carcinoma) cells were obtained from the American Type Culture Collection (Manassas, VA, USA). Tuberin-negative (TSC2À/À) and tuberin-positive (TSC2 þ / þ ) cells are rat fibroblasts derived from the Eker rat embryos homozygous for the Eker mutant and wild-type TSC2 gene, respectively (compare for example, Soucek et al., 1998b) . All cells were grown at 37 1C and 5% CO 2 in Dulbecco's modified Eagle's medium supplemented with 10% calf serum and antibiotics. The MAPK pathway was induced by 100 ng ml À1 PMA (Calbiochem, Darmstadt, Germany) for 24 h. MEK was inhibited by adding 1 mM U0126 (Cell Signaling, Danvers, MA, USA) for 24 h into the medium. mTOR activity was inhibited by 100 nM rapamycin (Calbiochem) for 10 h. Apoptosis was induced by treatment with 25 nM staurosporine (Sigma, Vienna, Austria) for 120 min. For cytofluorometric analyses subG1 cells (DNA degradation), cells were harvested by trypsinization and fixed by rapid submersion in ice-cold 85% ethanol and DNA was stained in 0.25 mg ml À1 propidium iodide, 0.05 mg ml À1 RNase, 0.1% Triton X-100 in citrate buffer, pH 7.8. Cells were analysed on a Beckton Dickinson FACScan (Beckton Dickinson, San Jose, CA, USA). For the analyses of the amount of subG1 cells after transient transfection GFP-positive cells were selectively gated and DNA distribution was analysed (Rosner et al., 2003) . To monitor nuclear chromatin condensation and cell death Hoechst 33258 (Sigma) and propidium iodide (Sigma) were added directly to the culture medium to final concentrations of 5 and 2 mg ml À1 , respectively. Viable and apoptotic cells were discerned and counted under the microscope (Freilinger et al., 2006) .
Transfections
For transfections the following plasmids were used: empty pCMV; pCMV-RasV12 (mutationally activated); pCMVRasN17 (dominant negative) (Clontech Laboratories Inc, Saint-Germain-en-Laye, France); the pRK7 vector, empty or harboring p70S6K ; pcDNA3 empty or harboring full-length human wild-type TSC2, or the TSC2 SATA mutant (mutations of the AKT phosphorylation sites Ser939A, Thr1462A) ; pRK7 harboring wild-type TSC2; pRK7 harboring TSC2 with the S1798A mutation of the preferred RSK1 phosphorylation site (Roux et al., 2004) ; the GFP-spectrin expression vector described in Kalejta et al., (1997) . Since the pRK7 plasmid is not selectable, in case of selection experiments cotransfections with pCMV have been performed. All cell transfections were performed using the Lipofectamine reagents obtained from Invitrogen (Life Technologies, Lofer, Austria) following the transfection protocol provided by the manufacturer.
Luciferase assays Cells were transfected as described above and cotransfected with a luciferase reporter plasmid. Cell pellets were lysed in reporter lysis buffer (Promega, Mannheim, Germany), and to achieve complete cell lysis, the cell suspensions were immediately frozen at À80 1C and then thawed rapidly. Subsequently the lysates were centrifuged at 12 000 g for 1 min at room temperature and the supernatant was assayed for luciferase activity. A total of 20 ml of supernatant were mixed with 100 ml luciferase assay reagent (Promega), and luminescence was measured with a luminometer (FLUOstar, BMG Labtechnologies, Offenburg, Germany). The luciferase activity was recorded as relative light units (Harada et al., 2001; Freilinger et al., 2006) .
Immunoblotting
Protein extraction and western blot analysis were performed as described (Freilinger et al., 2006) 
Statistical analysis
The significance of the observed differences was determined by Student's t-test (paired, two-tails) using GraphPad INSTAT software. P-values >0.05 are defined as not significant.
